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1. Introduction 
The methylxanthines caffeine, theophylline and 
theobromine are present in such widely consumed 
food-products as coffee, chocolate and tea. They have 
been used in medicines as respiratory and cardiac stim- 
ulants as well as diuretics [ 1,2]. 
in ammonia-dependent carbamyl phosphate synthetase 
(CPS I) and ornithine transcarbamylase (OTCase) 
activities in rats ingesting high concentrations of 
caffeine and theophylline, as well as increased blood 
levels of urea, and their correlation with self-mutilation. 
These compounds are potent mutagens in Escheri- 
chia coli and other lower organisms and have been 
shown to enhance the effect of other mutagenic agents 
such as ultraviolet light [3-61. Mammals, however, 
do not seem to be susceptible to such activity possibly 
because they can demethylate these compounds. 
Methylxanthines may induce chromosomal aberra- 
tions in cell cultures and have an antimitotic activity 
in some cellular systems. Caffeine has been shown to 
inhibit DNArepair mechanisms, thus allowing sublethal 
damage to chromosomes to become lethal [7-l I]. 
2. Materials and methods 
Rats and rabbits receiving high doses of caffeine 
mimic the behavior of Lesch-Nyhan patients 
[ 12,131. The Lesch-Nyhan syndrome is a neurologic 
X-linked disorder, characterized by mental retarda- 
tion and an aggressive attitude with self-destructive 
biting, and which is associated with a loss of hypo- 
xanthine guanine phosphoribosyltransferase activity 
[14-161. 
Groups of adult albino rats (200 g body wt) were 
maintained on an 18% protein diet and given 2,4 and 
8 g/l of caffeine or 4 g/l of theophylline in their drink- 
ing water for 50 days; 100 g/l of sucrose were added 
to mask the bitter taste of caffeine solutions. 
Levels of urea in blood taken from the tail were 
measured every 2 days in the first week and once a 
week thereafter. Body weight, liquid and food intake 
were recorded throughout the experiment. 
Activities of HGPRTase in erythrocytes, ATCase 
in erythrocytes, liver and brain, CPS I and OTCase in 
liver and acetylcholinesterase in erythrocytes and 
brain were measured. 
Hypoxanthlne guanine phosphoribosyltransferase 
in erythrocytes was measured by the method in [ 201 
as modified [17]. 
Tissues from children suffering from Lesch-Nyhan 
disease have an increased activity of some enzymes of 
the biosynthetic pathway for pyrimidines [ 17,181. 
However, although a number of parameters have been 
studied in mammals treated with caffeine [ 12,191, 
there have been no reports concerning its effect on 
nitrogen metabolism and biosynthesis of purines. We 
show here a decrease of hypoxanthine guanine phos- 
phoribosyltransferase (HGPRTase) and aspartate 
transcarbamylase (ATCase) activities and an increase 
Aspartate transcarbamylase in erythrocytes was 
assayed by a modification of the method in [ 171, 
with the addition of 0.007 IU of urease to the assay 
mixture. The carbamyl aspartate formed was estimated 
calorimetrically [21]. 
Liver, in 0.154 M KCl (1:9) and brain, in water 
(1:4), were homogenized in an Ultraturrax and 
ATCase was determined as described for erythrocytes. 
Carbamyl phosphate synthetase I and ornithine 
transcarbamylase were measured in liver homogenate 
(1:20). The assay for carbamyl phosphate synthetase 
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I included: 13.75 ~01 ammonium bicarbonate, 
2.75 ~01 magnesium sulfate, 1.375 ~01 ATP 
(pH 7.0), 1.375 ~01 N-acetylglutamate, 1.4 pg pyr- 
uvate kinase and 25 @ homogenate in a final volume 
of 275 4. Before the addition of pyruvate kinase the 
mixture was bubbled with CO*. The reaction was 
incubated 15 min at 37’C and stopped with 1 ml 15% 
HClO,; the citrulline formed was measured colorimet- 
rically [21]. For ornithine transcarbamylase the assay 
included 30 ~01 glycylglycine (pH 8.0) 20 ~01 
carbamyl phosphate, disodium salt, 15 ~01 L-orni- 
thine, water and 25 /.d homogenate in a final volume 
of 1 .O ml. After 15 min at 37°C the reaction was 
stopped with 2.5 ml 15% HClO, and the citrulline 
was measured. 
Acetylcholinesterase in erythrocytes and brain 
homogenate was assayed as in [22]. 
3. Results 
Rats imbibing daily high amounts of a caffeine 
solution (8 g/l) developed symptoms of self-biting 
before 15 days (80% of animals); a progressive loss 
of body weight was associated with these symptoms 
and most of the rats finally died. The animals that did 
not develop symptoms by approximately the 20th 
day remained apparently unaffected for the duration 
of the experiment (2 months). Females were 3-times 
more susceptible than males. The body weight, a 
week after the onset of the disorder, was decreased 
by 40% of control values (experimental mean value = 
133 + 30 g; control mean value = 225 + 20 g). The 
animals in the other two groups, given 2 and 4 g/l 
caffeine to drink, did not develop symptoms, although 
they showed a loss of body weight of 10% and 30%, 
respectively. The mean consumption of caffeine 
(males and females) was -200 mg . kg-‘. day-’ for 
the 2 groups with the higher concentrations of caf- 
feine in their drinking fluid and 120 mg . kg-’ . day-’ 
for the lower dose. 
A decrease in food and liquid intake, proportional 
to the concentration of caffeine in the drinking fluid, 
was observed at the beginning of the experiments. 
When caffeine administration was stopped, rats 
recovered their appetite and ate and drank as the con- 
trol animals; increasing the concentration of caffeine 
in the drinking fluid again caused a decreased intake 
(fig.1 a,b). 
Blood urea increased in all experimental rats from 
6.3~0.6~ol/mlbloodto8.7~1.2,10.3~1.4and 
11.2 + 1.3 mol/ml blood for groups receiving 2,4 and 
8 g/l of caffeine, respectively. After several days of 
treatment, these levels diminished to nearly steady 
values proportional to the intake (fig.2). On caffeine 
withdrawal blood urea decreased to normal values, 
while increasing the concentration of caffeine caused 
an elevation of urea in blood. 
The activity of HGPRTase in erythrocytes of rats 
treated with caffeine and with symptoms of self-biting 
was decreased to levels ranging from non-detectable 
to 2.95 nmol hypoxanthine . h-l . mg protein-‘. As 
illustrated in table 1, the mean value for controls was 
6.0 + 0.84 nmol . h-r. mg protein-‘, while for the 
experimental animals it was 1.4 f. 1.2 nmol . h-r. mg 
protein-‘. It is evident that control values for rats are 
markedly lower than those observed in humans [ 171. 
In table 1 we also show that the activity of ATCase 
in erythrocytes of animals with autodestructive 
behavior felI by X5%, that of liver and brain was 
day5 
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Fig.1. Daily food (a) and fluid (b) intake of rats treated with (0) 2 g/l caffeine, (A) 4 g/l caffeine and (=) 8 g/l caffeine, (---) 
mean of controls; (I) withdrawal of, and (t) increased dosage of caffeine. 
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Fig.2. Blood urea levels during treatment with (0) 2 g/l caf- 
feine, (A) 4 g/l caffeine and (u) 8 g/l caffeine. Urea was mea- 
sured as in [ 181; values are expressed as mean f SD; (---) 
mean of controls; (1) withdrawal of, and (t) increased dosage 
of caffeine. 
reduced to 38% and 36% of controls, respectively. 
CPS I and OTC&e activities showed increases of up to 
66% and 30% of controls, respectively. 
There were no significant changes in the activities 
of any of the enzymes tested in animals receiving 2 
and 4 g/l caffeine, nor in those receiving 8 g/l caffeine 
which showed no autodestructive behavior. 
Rats ingesting4 g/l theophylline showed symptoms 
similar to those receiving the highest dosage of caffeine 
(8 g/l); blood urea levels were enhanced and the activ- 
ity of erythrocyte ATCase was diminished to 5% that 
of controls. 
The incidence of self-biting in rats as a result of 
caffeine intake seems to be related more to the initial 
drug concentration than to the daily dose. Although 
the dose . kg body tit-‘. day-’ was greater when ani- 
mals were drinking 4 g/l caffeine (211 mg caffeine . 
kg-‘. day-‘), symptoms occurred only in animals 
receiving 8 g/l caffeine. In addition, the sensitivity to 
the treatment was apparently not related to habitua- 
tion, since the severity of symptoms was similar 
when the increase in dose was gradual and when the 
higher dose was given directly. Theophylline has 
proved to be more effective than caffeine in inducing 
auto-mutilation, since only half the concentration 
was needed. However, other animals which received 
theobromine and xanthine (in their food, because of 
low solubility in water), showed only a slight loss of 
weight. 
Concerning the activity of acetylcholinesterase, 
the measurements in erythrocytes and brain of rats 
ingesting 8 g/l caffeine and with self-biting were found 
to be similar to those of controls (mean control 
values = 6.6 f 0.7 nmol thiocholine . min-’ . mg pro- 
tein-’ for erythrocytes and 139 + 9 nmol . min-’ . mg 
protein-’ for brain; mean experimental values = 
11 .O f 7.1 nmol thiocholine . min-’ . mg protein-’ 
for erythrocytes and 121 f 18.9 nmol . min-’ . mg 
protein-’ for brain). 
Table 1 
Hypoxanthineguanine phosphoribosyltransferase, aspartate transcarbamylase, carbarnylphosphate 
synthetase I and ornithine transcarbamylase activities in tissues of rats treated with caffeine and with 
behavioral symptoms 
















6.0 * 0.8 (7) 1.4 f 1.2 (9) <O.OOl 
9.2 f 2.5 (10) 0.4 * 0.4 (5) <O.OOl 
143.0 i 42.0 (11) 87.7 f 23.0 (3) <o.os 
34.7 * 7.8 (9) 22.2 * 12.4 (4) <0.05 
146.6 f 17.0 (17) 247.7 + 22.0 (4) <o.oo 1 
11 619 * 1548 (7) 15 017 f 779 (4) <0.05 
HGPRTase and ATCase values are expressed in nmol . h-’ . mg protein“ and CPS I and OTCase in 
pmol . h-’ . mg protein-’ ; numbers in parentheses indicate size of sample 
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4. Discussion 
Considering that 40 mg caffeine, the average ingested 
per rat per day, could be transformed into a maximum 
of 400 pmol urea, and that the daily protein intake 
(1.8 g . rat-’ . day-‘) can produce 10.8 mmol urea, it 
is apparent that the increased levels of urea in blood 
cannot be explained simply as the result of urea pro- 
duced from caffeine metabolism but rather by increased 
synthesis, since the activities of the enzymes CPS I 
and OTC&e are increased. 
Addition of methyl-xanthines to particulate frac- 
tions of tissue homogenates increases cyclic 3’,5’-AMP 
levels by inhibiting the cyclic 3’,5’-nucleotide phos- 
phodiesterase [23]. The increased urea synthesis could 
be due to the stimulation of mitochondrial function 
as a consequence of the high CAMP levels produced 
by the administration of caffeine. 
Many attempts have been made to produce uremia 
in animals as a model for renal failure [24-261. These 
results indicate that caffeine is an effective agent for 
increasing the urea levels in rats, so it may prove use- 
ful for such studies. 
Although 4 of the 6 enzymes of pyrimidine bio- 
synthesis have been found elevated in HGPRTase- 
deficient erythrocytes, the mechanism has not yet 
been established [ 17,181. 
The decrease in activity of HGPRTase in animals 
treated with caffeine and showing self-destructive 
behavior resembles those first shown in Lesch-Nyhan 
syndrome [27]. However, HGPRTase activity in 
patients was decreased to <l% of controls, while in 
rats showing neurological symptoms HGPRTase 
activity was usually undetectable but was occasion- 
ally decreased only 50% that of the controls. From 
these results it appears that caffeine may be helpful 
in clarifying this disease, particularly since there are 
many variants of the syndrome. That symptoms 
develop in rats with apparently less depletion of the 
enzyme than in humans may reflect their lower nor- 
mal levels of enzyme activity. A cup of coffee or tea 
may contain up to 150 mg caffeine, which would be 
equivalent to some 750 mg/l. This is approximately 
half the concentration needed as drinking fluid to 
increase blood urea levels 30-40% or 1/8th of that 
needed to develop autodestructive behavior in rats. 
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